Cousin et al evaluated patients after elective colorectal cancer using serum C-reactive protein (CRP) or procalcitonin. The serum concentrations between 3 and 5 days after surgery can help to identify a patient at low risk for intra-abdominal infection. The authors are from Dijon University in France and Sapienza University of Rome.
